
### [MONDO:0020272](http://purl.obolibrary.org/obo/MONDO_0020272)
**Label:** connective tissue disease with eye involvement

**Subclasses:** [MONDO:0009925](http://purl.obolibrary.org/obo/MONDO_0009925) (pseudoxanthoma elasticum), [MONDO:0009242](http://purl.obolibrary.org/obo/MONDO_0009242) (brittle cornea syndrome), [MONDO:0010592](http://purl.obolibrary.org/obo/MONDO_0010592) (focal dermal hypoplasia), [MONDO:0016002](http://purl.obolibrary.org/obo/MONDO_0016002) (Ehlers-Danlos syndrome, kyphoscoliotic type), [MONDO:0008333](http://purl.obolibrary.org/obo/MONDO_0008333) (pseudoxanthoma elasticum, Forme Fruste), [MONDO:0013605](http://purl.obolibrary.org/obo/MONDO_0013605) (brittle cornea syndrome 2), [MONDO:0007947](http://purl.obolibrary.org/obo/MONDO_0007947) (Marfan syndrome), [MONDO:0017308](http://purl.obolibrary.org/obo/MONDO_0017308) (Marfan syndrome type 2), 

**Corr. equiv. classes:** [Orphanet:284973](http://www.orpha.net/ORDO/Orphanet_284973), [OMIM:305600](http://purl.obolibrary.org/obo/OMIM_305600), [Orphanet:284963](http://www.orpha.net/ORDO/Orphanet_284963), [OMIM:177850](http://purl.obolibrary.org/obo/OMIM_177850), [OMIM:614170](http://purl.obolibrary.org/obo/OMIM_614170), [Orphanet:2092](http://www.orpha.net/ORDO/Orphanet_2092), [OMIM:154700](http://purl.obolibrary.org/obo/OMIM_154700), [OMIM:229200](http://purl.obolibrary.org/obo/OMIM_229200), [OMIM:264800](http://purl.obolibrary.org/obo/OMIM_264800), [Orphanet:558](http://www.orpha.net/ORDO/Orphanet_558), [Orphanet:758](http://www.orpha.net/ORDO/Orphanet_758), [Orphanet:1900](http://www.orpha.net/ORDO/Orphanet_1900), [Orphanet:90354](http://www.orpha.net/ORDO/Orphanet_90354), 

**Class expressions from DL-Learner:**

- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0011004](http://purl.obolibrary.org/obo/HP_0011004) (Abnormal systemic arterial morphology) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0004329](http://purl.obolibrary.org/obo/HP_0004329) (Abnormality of the posterior segment of the globe) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011004](http://purl.obolibrary.org/obo/HP_0011004) (Abnormal systemic arterial morphology) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001098](http://purl.obolibrary.org/obo/HP_0001098) (Abnormality of the fundus) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) 65.38%
- [HP:0000479](http://purl.obolibrary.org/obo/HP_0000479) (Abnormal retinal morphology) and [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) 65.38%
- [HP:0000505](http://purl.obolibrary.org/obo/HP_0000505) (Visual impairment) and [HP:0001634](http://purl.obolibrary.org/obo/HP_0001634) (Mitral valve prolapse) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 64.87%


